Hypertension Review
THE REVIEW
Access to this activity is free, but you'll be required to register prior to accessing the CEU exam on the Nurses Learning Network.
First download and read the article. If you have a printer available, you may print a copy of the article. When you are ready to take the exam, click below on the link to the exam. If you are not registered on the Nurses Learning Network, you will need to in order to see the results of the exam and receive your certificate. Once scored, you'll need to complete an evaluation form; your CEU certificate will then be displayed on the screen for printing.
Click here to download:
Hypertension Review (PDF* 344KB)
Click here for:
CPE Exam and Certificate
LEARNING OBJECTIVES
Upon completion of this activity, participants will be able to:
- Be able to list the main types of antihypertensive medications.
- Be able to describe the principle of counter adaptation and understand its impact on blood pressure management.
- Be able to state at least two KDOQI recommendations regarding blood pressure management.
- Understand the differences between systolic and diastolic blood pressure.
CME / CE RELATED INFORMATION
Date of Release: January 24, 2004
CPE Credit Eligible Through: January 24, 2006
Target Audiences: This activity is designed for dietitians who are involved with the care and treatment of patients with chronic kidney disease (CKD).
Method of Participation: Read the article and complete the post-test and program evaluation.
STATEMENT OF NEED:
In the U.S. alone, 20 million adults have CKD and another 20 million are at increased risk for developing CKD. Most people with CKD develop anemia due to insufficient production of erythropoietin (EPO) by the diseased kidneys. When untreated, anemia of CKD is associated with a number of physiological abnormalities including decreased oxygen delivery and utilization, increased cardiac output, congestive heart failure, decreased cognitive ability and impaired immune responsiveness. These abnormalities reduce quality of life, compromise opportunities for rehabilitation and decrease patient survival. Clinicians must recognize their role in the effective treatment of the anemia of CKD so they can improve survival, decrease morbidity and improve the quality of life of their patients. Overall outcomes of CKD patients could be improved significantly by the appropriate evaluation and management of anemia. There is a growing need for awareness and understanding of issues related to anemia management in CKD by health care providers to improve patient outcomes on an ongoing basis.
ACCREDITATION STATEMENTS:
This article is approved for 1 CEU by ADA's Commission on Dietetic Registration (CDR). Maintain a copy as your certificate of completion. For those still using the past reporting system, please complete the questionnaire and submit directly to CDR to obtain credit. For those members that are part of the portfolio system, track your completion in your Step Activity Log.
DISCLAIMER:
The National Kidney Foundation does not assume any responsibility for any injury and/or damage to persons or property arising out of or related to any use of the material contained in this periodical. The reader is advised to check the appropriate medical literature and the product information currently provided by the manufacturer of each drug to be administered to verify the dosage, the methods and duration of administration, or contraindications. It is the responsibility of the treating physician or other health care professional, relying on independent experience and knowledge of the patient, to determine drug dosages and the best treatment for the patient.
USER INSTRUCTIONS:
To complete this educational activity, the user will need Windows or Macintosh operating software, a connection to the internet with a 28.8 kbps MODEM or better. Acrobat Reader is required to print the CME or CE certificate, and this can be downloaded free from www.adobe.com.
For any questions concerning this activity please send an email to maritzao@kidney.org.
